Literature DB >> 18479348

Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate.

Omai B Garner1, Yu Yamaguchi, Jeffrey D Esko, Vibeke Videm.   

Abstract

We have examined the role of heparan sulphate in lymphocyte development and activation in mice by conditionally deleting the genes encoding the heparan sulphate biosynthetic enzymes N-deacetylase/N-sulphotransferase-1 and -2 (Ndst1 and Ndst2) and glucuronic acid/N-acetylglucosamine co-polymerase-1 (Ext1) in T cells and B cells, respectively. Ndst1 and Ndst2 are the only Ndst isoforms in T cells. In T-cell Ndst-deficient mice there were normal ratios of CD4(+)/CD8(+) cells in the blood, spleen and thymus, indicating no dramatic effect on development. However, Ndst-deficient T cells were hyperresponsive to low-level activation, suggesting that cell surface heparan sulphate plays a role in T-cell proliferation. The hyperresponsive state correlated with a decrease in cell surface heparan sulphate that occurs in response to activation in wild-type cells. There was a slight change in the number of developing B cells in B-cell Ext1-deficient mice, but the alteration did not cause a change in antibody production. These findings demonstrate that cell surface heparan sulphate may not play a crucial role in lymphocyte development, but can modulate the sensitivity of T cells to activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479348      PMCID: PMC2669145          DOI: 10.1111/j.1365-2567.2008.02856.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

Review 1.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface.

Authors:  J Cladera; I Martin; P O'Shea
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

Review 3.  Molecular diversity of heparan sulfate.

Authors:  J D Esko; U Lindahl
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

4.  CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.

Authors:  D Chen; R J McKallip; A Zeytun; Y Do; C Lombard; J L Robertson; T W Mak; P S Nagarkatti; M Nagarkatti
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

5.  Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators.

Authors:  T Kouro; K L Medina; K Oritani; P W Kincade
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

Review 6.  Selection events operating at various stages in B cell development.

Authors:  A G Rolink; C Schaniel; J Andersson; F Melchers
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

7.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation.

Authors:  M Demetriou; M Granovsky; S Quaggin; J W Dennis
Journal:  Nature       Date:  2001-02-08       Impact factor: 49.962

8.  Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice.

Authors:  X Lin; G Wei; Z Shi; L Dryer; J D Esko; D E Wells; M M Matzuk
Journal:  Dev Biol       Date:  2000-08-15       Impact factor: 3.582

9.  Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice.

Authors:  R Stoop; H Kotani; J D McNeish; I G Otterness; K Mikecz
Journal:  Arthritis Rheum       Date:  2001-12

10.  Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans.

Authors:  R van der Voort; R M Keehnen; E A Beuling; M Spaargaren; S T Pals
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

View more
  17 in total

1.  Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN.

Authors:  Nadine Jarousse; Damian L Trujillo; Sarah Wilcox-Adelman; Laurent Coscoy
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

Review 2.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

3.  Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes.

Authors:  Xingfeng Bao; E Ashley Moseman; Hideo Saito; Bronislawa Petryniak; Bronislawa Petryanik; Aude Thiriot; Shingo Hatakeyama; Yuki Ito; Hiroto Kawashima; Yu Yamaguchi; John B Lowe; Ulrich H von Andrian; Minoru Fukuda
Journal:  Immunity       Date:  2010-11-24       Impact factor: 31.745

4.  Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity.

Authors:  Ding Xu; Joshua Olson; Jason N Cole; Xander M van Wijk; Volker Brinkmann; Arturo Zychlinsky; Victor Nizet; Jeffrey D Esko; Yung-Chi Chang
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

Review 5.  Glycobiology and the growth plate: current concepts in multiple hereditary exostoses.

Authors:  Kevin B Jones
Journal:  J Pediatr Orthop       Date:  2011 Jul-Aug       Impact factor: 2.324

6.  Impact of the gut microbiota on enhancer accessibility in gut intraepithelial lymphocytes.

Authors:  Nicholas P Semenkovich; Joseph D Planer; Philip P Ahern; Nicholas W Griffin; Charles Y Lin; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-01       Impact factor: 11.205

Review 7.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

8.  Hs2st mediated kidney mesenchyme induction regulates early ureteric bud branching.

Authors:  Mita M Shah; Hiroyuki Sakurai; Derina E Sweeney; Thomas F Gallegos; Kevin T Bush; Jeffrey D Esko; Sanjay K Nigam
Journal:  Dev Biol       Date:  2010-01-06       Impact factor: 3.582

9.  Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response.

Authors:  Smruti Killedar; Julianne Dirosario; Erin Divers; Phillip G Popovich; Douglas M McCarty; Haiyan Fu
Journal:  J Neuroinflammation       Date:  2010-07-16       Impact factor: 8.322

10.  Deficiency of endothelial heparan sulfates attenuates allergic airway inflammation.

Authors:  Riaz I Zuberi; Xiao Na Ge; Shuxia Jiang; Nooshin S Bahaie; Bit Na Kang; Reza M Hosseinkhani; Elizabeth M Frenzel; Mark M Fuster; Jeffrey D Esko; Savita P Rao; P Sriramarao
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.